Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 32,317

Document Document Title
WO/2017/116646A1
Disclosed are compounds of Formulae 1, 1a, 1b and 2, INSERT FORMULAE 1, 1A, 1B AND 2 wherein R1, R1a, R1b, R2, R3 and R4 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formulae 1, 1a and 1b,...  
WO/2017/108282A1
A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in terepy, e.g. in the treatment of autoimmune disorders, mental disorders, ne...  
WO/2017/111543A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same, the compound, according to the present invention, being used on an organic layer, preferably a light-emitting layer, of an organi...  
WO/2017/107567A1
A method for treating atopic dermatitis in a subject in need thereof is provided. The method includes administering to the subject a composition containing a therapeutically effective amount of a melatonin associated compound and a pharm...  
WO/2017/111544A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound according to the present invention can be used in an organic layer, and more desirably, in a light emitting layer or...  
WO/2017/106974A1
Two isoforms of thyroid receptor alpha (THRα1 and THRα2) have been found to be associated with the growth of cancer. Use of inhibitors of THRα1 (Formula I) and/or agonists of THRα2 (Formula II) in the treatment of such cancers is dis...  
WO/2017/103838A1
The embodiments herein provide a method for synthesizing solvent free sesamin complex 90% extract. The crude sesame oil is extracted repeatedly with polar solvents. The extracts are concentrated to obtain a thick paste that is washed wit...  
WO/2017/105106A1
The present invention relates to a novel compound and an organic electroluminescent element including same. The compound according to the present invention may be used in an organic layer of an organic electroluminescent element and pref...  
WO/2017/102063A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2017/100967A1
Provided are a benzo[c]phenanthrene derivative with an electron donor-acceptor structure and a use thereof and an electroluminescent device. Such a derivative takes benzo[c]phenanthrene as a core, and forms an efficient fluorescence ligh...  
WO/2017/105211A1
The present invention relates to the use of compounds derived from calyces of Jamaican sorrel (Hibiscus sabdariffa) with antimicrobial activity, which can be used in different areas of microbiology, for example, medical microbiology, vet...  
WO/2017/106520A1
Disclosed are compounds of formulas I and II, in which R, R0, R1-R4, R7-R10, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds. The compounds and pharmaceutical compositions are for use in ...  
WO/2017/101515A1
A new crystalline form of spirodiclofen of formula (I), the crystal preparation process, the analyses of the crystal through various analytical methods and using the crystal to prepare stable agrochemical formulation. Also described is t...  
WO/2017/106591A1
A process to produce furandicarboxylic acid (FDCA). The process includes the steps of reacting a C6 sugar-containing reactant in a reaction solution comprising a first organic solvent selected from the group consisting of beta-, gamma-, ...  
WO/2017/102064A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2017/104994A1
Disclosed are: a compound represented by chemical formula 1; an organic electronic element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode; and an electronic dev...  
WO/2017/098254A1
The present invention provides a modulator of Kv3.1 and/or Kv3.2 and/or Kv3.3 channels for use in the prophylaxis or treatment of pain. Modulators for use in the prophylaxis or treatment of pain include compounds of formula (I) or a phar...  
WO/2017/100268A1
Provided herein are methods of treatment for kidney stones, e.g., for controlling or inhibiting the formation of calcium oxalate kidney stones by inhibiting the production of glyoxylate and/or oxalate, treatment of primary hyperoxaluria,...  
WO/2017/099471A1
The present specification provides a heterocyclic compound and an organic light emitting element comprising the same.  
WO/2017/097843A1
The present invention relates to a process for the production of 2,5-furandicarboxylic acid (FDCA) via oxidation of 5-hydroxymethyl-2-furfural (HMF), said HMF being present in a solution in a high-boiling polar solvent and water. The pro...  
WO/2017/100402A1
A procedure for preparing anhydropentitol mono, di, and tri esters is described. The process is performed in a single vessel and involves sequential dehydrative cyclization and carboxylic acid acylation steps. Each step is catalyzed by l...  
WO/2017/099490A1
The present application provides: a heterocyclic compound capable of significantly improving the lifetime, efficiency, electrochemical stability, and thermal stability of an organic light emitting element; and an organic light emitting e...  
WO/2017/099572A1
The present invention relates to extracts/fractions and compounds obtained from same, which comprise diterpenes, isolated from Salvia amarissima, with a novel, non-conventional carbon skeleton, and to the pharmacological properties there...  
WO/2017/093272A1
The invention relates to fur an e derivatives of formula (I) as inhibitors of ATAD2, a process for their preparation and use thereof.  
WO/2017/091956A1
The invention relates to a process for separating and purifying gibberellin GA3 by using a magnetic resin, and belongs to the field of biological separation. The process comprises the following steps: passing an acidified residual separa...  
WO/2017/095704A1
Polymerizable compositions comprising a redox initiator system is disclosed. The redox initiators comprises a photolabile reducing agent, that photolyzes and initiates the redox cycle. Dental compositions comprising dental resins and the...  
WO/2017/095237A1
The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to prot...  
WO/2017/095054A1
Disclosed are: an organic-electric element including a compound represented by Chemical Formula 1, a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode; and an electron...  
WO/2017/095075A1
The present invention provides a novel compound capable of improving the luminous efficiency, stability and lifespan of a device, an organic electric device using the same, and an electronic device .  
WO/2017/091412A1
A method for preparing sugar-based oligomers is described. The process involves sequential (one-pot) esterification of 2,5-furan-dicarboxylic acid (FDCA) with an alcohol and transesterification with a glycol, as catalyzed by relatively l...  
WO/2017/090601A1
Provided is an industrially useful method for producing an aromatic heteropolycyclic halogen compound. Said method for producing an aromatic heteropolycyclic halogen compound is characterized in that an aromatic heteropolycyclic compound...  
WO/2017/090918A1
The present invention provides a novel compound capable of improving the luminous efficiency, stability, and life of an element, an organic electronic element using same, and an electronic device comprising same.  
WO/2017/086723A1
The present specification provides a spiro compound and an organic light-emitting element comprising same.  
WO/2017/085986A1
Provided is a method for producing γ-valerolactone which ensures a high productivity with suppressed elution of metal components. γ-Valerolactone is synthesized by contacting a levulinic acid compound represented by formula (1) [wherei...  
WO/2017/086357A1
The present invention provides an organic EL element comprising at least a positive electrode, a hole transport layer, a light emitting layer, an electron transport layer, and a negative electrode, in this order, said organic EL element ...  
WO/2017/086706A1
The present invention provides: a compound capable of increasing high emission efficiency, a low driving voltage, and the life span of an element; an organic electric element using the same; and an electronic device therefor.  
WO/2017/087965A1
Processes and compositions for 2-heteroaryl substituted benzofuran derivatives are described. The 2-heteroaryl substituted benzofuran derivatives may be suitable for preparing radiolabeled 2-heteroaryl substituted benzofuran derivatives ...  
WO/2017/083488A1
The present application discloses 2-phenyl benzofuran derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and c...  
WO/2017/082556A1
The present invention relates to a compound represented by [chemical formula A] or [chemical formula B] and an organic light-emitting device comprising same.  
WO/2017/082574A1
The present invention relates to an organic compound represented by [chemical formula A] or [chemical formula B] and an organic light-emitting device comprising same.  
WO/2017/083297A1
A process for production of 2,5-furandicarboxylic acid (FDCA) is provided. The process comprises reacting a compound having a formula of R1OOC(CHOH)4COOR2, wherein R1 and R2 are selected from the group consisting of alkali metal, alkalin...  
WO/2017/083242A1
Compounds capable of inhibiting suppression of tumorgenicity 2 (ST2) are disclosed. The compounds are useful in the treatment of a variety of diseases and conditions, such as alleviation of graft-versus-host disease (GVHD), cardiovascula...  
WO/2017/078494A1
The present application provides: a heterocyclic compound capable of greatly improving the lifespan, efficiency, electrochemical stability and thermal stability of an organic light emitting device; and an organic light emitting device ha...  
WO/2017/079719A1
Disclosed are compounds of the Formula 1 wherein A is an aromatic moiety; H is a hydrophobic group comprising a main alkyl chain having from about 3 to about 26 carbon atoms and comprising a C2 or greater alkyl chain branched from the ma...  
WO/2017/079718A1
Methods that include acylating an aromatic containing compound by reacting the aromatic containing compound with an anhydride containing compound to form an acylated aromatic containing compound.  
WO/2017/076626A1
The invention relates to a novel method for converting a filler comprising at least one sugar into 5-hydroxymethylfurfural, in which said filler is brought into contact with at least one catalyst of the family of homogeneous sulfonic aci...  
WO/2017/076947A1
The invention relates to a process for preparing furan-2,5-dicarboxylic acid comprising the following steps: (a) preparing or providing a starting material mixture comprising 5-(hydroxymethyl)furfural (HMF) as a first reactant and one or...  
WO/2017/076625A1
The invention relates to a method for producing 5-hydroxymethylfurfural from a filler comprising at least one sugar, using a combination of at least one catalyst selected from the homogeneous Lewis acids, the heterogeneous Lewis acids an...  
WO/2017/076942A1
The present invention relates to a process for preparing a mixture comprising 5-(hydroxy- methyl)furfural (HMF) and one or more HMF esters of formula (I, the process comprising the following steps: (A-1) preparing or providing a starting...  
WO/2017/076956A1
The present invention relates to a process for preparing furan-2,5-dicarboxylic acid, the process comprising the following steps: (A-1) preparing or providing a starting mixture comprising one, two or more carbohydrate compounds selected...  

Matches 401 - 450 out of 32,317